Abstract
In multicellular organisms, unnecessary or harmful cells, such as those that are cancerous or infected with a virus, are eliminated by apoptosis. After apoptosis, cell corpses are rapidly recognized and phagocytosed by professional phagocytes, such as macrophages and dendritic cells. The rapid removal of cell corpses by phagocytes prevents the release of potentially toxic or immunogenic materials from dying cells. Although a number of molecules on phagocytes have been found to be involved in apoptotic cell clearance in vitro, only a few have been proved to be involved in apoptotic cell clearance in vivo by analyses of knockout animals. These knockout mice commonly suffer from autoimmunity, indicating that the complete removal of apoptotic cells is essential for the maintenance of selftolerance. In this review, we present an overview of the molecular mechanisms of apoptotic cell clearance by phagocytes and the pathological relevance of the failure of apoptotic cell clearance to autoimmune disorder.
Keywords: Apoptosis, phagocytosis, macrophage, dendritic cell, autoimmune disease, self-tolerance
Current Medicinal Chemistry
Title: Apoptotic Cell Clearance and Autoimmune Disorder
Volume: 14 Issue: 27
Author(s): Masato Tanaka and Yasunobu Miyake
Affiliation:
Keywords: Apoptosis, phagocytosis, macrophage, dendritic cell, autoimmune disease, self-tolerance
Abstract: In multicellular organisms, unnecessary or harmful cells, such as those that are cancerous or infected with a virus, are eliminated by apoptosis. After apoptosis, cell corpses are rapidly recognized and phagocytosed by professional phagocytes, such as macrophages and dendritic cells. The rapid removal of cell corpses by phagocytes prevents the release of potentially toxic or immunogenic materials from dying cells. Although a number of molecules on phagocytes have been found to be involved in apoptotic cell clearance in vitro, only a few have been proved to be involved in apoptotic cell clearance in vivo by analyses of knockout animals. These knockout mice commonly suffer from autoimmunity, indicating that the complete removal of apoptotic cells is essential for the maintenance of selftolerance. In this review, we present an overview of the molecular mechanisms of apoptotic cell clearance by phagocytes and the pathological relevance of the failure of apoptotic cell clearance to autoimmune disorder.
Export Options
About this article
Cite this article as:
Tanaka Masato and Miyake Yasunobu, Apoptotic Cell Clearance and Autoimmune Disorder, Current Medicinal Chemistry 2007; 14 (27) . https://dx.doi.org/10.2174/092986707782360006
DOI https://dx.doi.org/10.2174/092986707782360006 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Melatonin in Multiple Sclerosis, Huntington's Disease and Cerebral Ischemia
CNS & Neurological Disorders - Drug Targets Anti-Inflammatory Properties of Drugs from saffron crocus
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Brain Targeted Drug Delivery: Factors, Approaches and Patents
Recent Patents on Nanomedicine The Role of STATs in Inflammation and Inflammatory Diseases
Current Pharmaceutical Design The Main Receptors Involved in the COVID-19: A Systematic Review and Meta-Analysis
Current Medicinal Chemistry Update to Medicinal Chemistry of Nicotinamide in the Treatment of Ischemia and Reperfusion
Medicinal Chemistry Reviews - Online (Discontinued) Mesenchymal stem cell therapy for inflammatory bowel diseases: promise and challenge
Current Stem Cell Research & Therapy Protective Effects of Melatonin and Mitochondria-targeted Antioxidants Against Oxidative Stress: A Review
Current Medicinal Chemistry Immune Deviation Strategies in the Therapy of Psoriasis
Current Drug Targets - Inflammation & Allergy CTLA-4Ig: Uses and Future Directions
Recent Patents on Inflammation & Allergy Drug Discovery Microglial Senescence
CNS & Neurological Disorders - Drug Targets Contrasting Roles of the Galectin-3 in the Schizophrenia Onset, Clinical Presentation, and Somatic Comorbidity
Current Topics in Medicinal Chemistry The p35 Family of Apoptosis Inhibitors
Current Genomics Editorial: [Hot Topic: Central Nervous System Drugs in the Treatment of Neurological Disorders]
Central Nervous System Agents in Medicinal Chemistry Pathogenic Bacterial Proteins and their Anti-Inflammatory Effects in the Eukaryotic Host
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cellular and Biochemical Actions of Melatonin which Protect Against Free Radicals: Role in Neurodegenerative Disorders
Current Neuropharmacology Interleukin-4-Induced Oxidative Stress Via Microglial NADPH Oxidase Contributes to the Death of Hippocampal Neurons In Vivo
Current Aging Science Viral Anti-Inflammatory Reagents: The Potential for Treatment of Arthritic and Vasculitic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Organotypic Cultures as Tool to Test Long-Term Effects of Chemicals on the Nervous System
Current Medicinal Chemistry In Vivo DNA Electrotransfer for Immunotherapy of Cancer and Neurodegenerative Diseases
Current Drug Metabolism